<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="171449">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00864461</url>
  </required_header>
  <id_info>
    <org_study_id>249-08</org_study_id>
    <nct_id>NCT00864461</nct_id>
  </id_info>
  <brief_title>Frequency of Metabolic Syndrome in Down Syndrome Patients</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad de Guanajuato</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidad de Guanajuato</source>
  <brief_summary>
    <textblock>
      The aim of this study is to assess the frequency of metabolic syndrome in Down syndrome
      patients because the prevalence of diabetes mellitus and obesity is higher in individuals
      with Down syndrome than in the general population.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>May 2009</start_date>
  <completion_date type="Anticipated">July 2009</completion_date>
  <primary_completion_date type="Anticipated">May 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To asses the frequency of the metabolic syndrome among Down syndrome patients. Metabolic syndrome was defined by Adult Tratment Panel III criteria modified by Halley Castillo.</measure>
    <time_frame>One year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluate the insulin resistance and insulin sensitivity using the HOMA and QUICKY methods.</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">96</enrollment>
  <condition>Metabolic Syndrome X</condition>
  <condition>Down Syndrome</condition>
  <arm_group>
    <arm_group_label>Case</arm_group_label>
    <description>Patients with clinical and cytogenetics diagnosis of Down syndrome, between 7 - 24 years old.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Siblings of the same gender of the case, between 7-24 years old.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Community sample
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of Down syndrome

        Exclusion Criteria:

          -  History of congenital cardiac defects requiring open-heart surgery

          -  History of gastroenterologic anomalies requirin bowel resection and/or ongoing
             medical intervention

          -  History of leukemia or other cancer

          -  History of hypothyroidism requiring thyroid hormone replacement
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>24 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Alejandro E Macias, MD</last_name>
    <phone>01477 7 14 58 59</phone>
    <phone_ext>401</phone_ext>
    <email>aaeemmhh@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>School of Medicine, University of Guanajuato</name>
      <address>
        <city>Leon</city>
        <state>Guanajuato</state>
        <zip>37320</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alejandro E Macías, MD</last_name>
      <phone>01477 7 14 58 59</phone>
      <phone_ext>401</phone_ext>
      <email>aaeemmhh@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <verification_date>March 2009</verification_date>
  <lastchanged_date>March 17, 2009</lastchanged_date>
  <firstreceived_date>March 17, 2009</firstreceived_date>
  <responsible_party>
    <name_title>Dr. Alejandro Ernesto Macías Hernández</name_title>
    <organization>School of Medicine of Leon, University of Guanajuato</organization>
  </responsible_party>
  <keyword>Down syndrome</keyword>
  <keyword>Metabolis syndrome X</keyword>
  <keyword>Insulin resistance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Metabolic Syndrome X</mesh_term>
    <mesh_term>Down Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
